Tetsuro Ohmori

7.2k total citations
180 papers, 4.4k citations indexed

About

Tetsuro Ohmori is a scholar working on Psychiatry and Mental health, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tetsuro Ohmori has authored 180 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Psychiatry and Mental health, 46 papers in Molecular Biology and 43 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tetsuro Ohmori's work include Schizophrenia research and treatment (34 papers), Tryptophan and brain disorders (26 papers) and Neuroscience and Neuropharmacology Research (26 papers). Tetsuro Ohmori is often cited by papers focused on Schizophrenia research and treatment (34 papers), Tryptophan and brain disorders (26 papers) and Neuroscience and Neuropharmacology Research (26 papers). Tetsuro Ohmori collaborates with scholars based in Japan, United States and Switzerland. Tetsuro Ohmori's co-authors include Shusuke Numata, Tsukasa Koyama, Tomohiro Abekawa, Jun‐ichi Iga, Y Kaneda, Shuichi Ueno, Satsuki Sumitani, Masahito Nakataki, Makoto Kinoshita and Shin’Ya Tayoshi and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biological Psychiatry.

In The Last Decade

Tetsuro Ohmori

176 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuro Ohmori Japan 37 1.3k 1.3k 1.2k 830 774 180 4.4k
Chen‐Jee Hong Taiwan 39 1.0k 0.8× 1.9k 1.5× 907 0.8× 1.1k 1.3× 613 0.8× 114 4.2k
Michael B. Knable United States 32 1.3k 0.9× 1.9k 1.5× 1.5k 1.3× 929 1.1× 792 1.0× 68 4.8k
Cristina Lorenzi Italy 40 2.1k 1.6× 1.2k 1.0× 888 0.8× 860 1.0× 913 1.2× 137 4.9k
Uriel Heresco‐Levy Israel 33 1.3k 1.0× 2.2k 1.8× 1.2k 1.0× 733 0.9× 1.3k 1.7× 72 4.7k
Nicola G. Cascella United States 34 1.2k 0.9× 1.0k 0.8× 1.0k 0.9× 1.0k 1.2× 450 0.6× 82 4.0k
Felice Iasevoli Italy 39 1.2k 0.9× 1.3k 1.0× 985 0.9× 546 0.7× 731 0.9× 144 4.0k
Peter Zill Germany 39 1.0k 0.8× 1.8k 1.4× 1.2k 1.0× 647 0.8× 843 1.1× 131 5.1k
Ichiro Kusumi Japan 34 1.2k 0.9× 724 0.6× 1.1k 0.9× 540 0.7× 508 0.7× 206 4.1k
Stephen Kanes United States 36 1.3k 1.0× 1.1k 0.8× 849 0.7× 1.2k 1.4× 653 0.8× 85 4.6k
Taro Kishi Japan 42 1.9k 1.4× 1.1k 0.8× 883 0.8× 781 0.9× 834 1.1× 233 5.5k

Countries citing papers authored by Tetsuro Ohmori

Since Specialization
Citations

This map shows the geographic impact of Tetsuro Ohmori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuro Ohmori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuro Ohmori more than expected).

Fields of papers citing papers by Tetsuro Ohmori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuro Ohmori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuro Ohmori. The network helps show where Tetsuro Ohmori may publish in the future.

Co-authorship network of co-authors of Tetsuro Ohmori

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuro Ohmori. A scholar is included among the top collaborators of Tetsuro Ohmori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuro Ohmori. Tetsuro Ohmori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okada, Go, Satoshi Yokoyama, Masahiro Takamura, et al.. (2022). Left DLPFC activity is associated with plasma kynurenine levels and can predict treatment response to escitalopram in major depressive disorder. Psychiatry and Clinical Neurosciences. 76(8). 367–376. 7 indexed citations
2.
Balan, Shabeesh, Tetsuo Ohnishi, Akiko Watanabe, et al.. (2021). Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia. Schizophrenia Bulletin. 47(4). 1190–1200. 11 indexed citations
3.
Yamazaki, Kiyohiro, Yuta Yoshino, Kentaro Kawabe, et al.. (2020). <p>ABCA7 Gene Expression and Genetic Association Study in Schizophrenia</p>. Neuropsychiatric Disease and Treatment. Volume 16. 441–446. 3 indexed citations
4.
Okazaki, Kenji, Ikuo Otsuka, Shusuke Numata, et al.. (2019). Epigenetic clock analysis of blood samples from Japanese schizophrenia patients. Schizophrenia. 5(1). 4–4. 31 indexed citations
5.
Tomotake, Masahito, Tsunehiko Tanaka, Shinya Watanabe, et al.. (2018). Relationship between social and cognitive functions in people with schizophrenia. Neuropsychiatric Disease and Treatment. Volume 14. 2215–2224. 19 indexed citations
6.
Sumitani, Satsuki, et al.. (2017). Prefrontal cortex activation during neuropsychological tasks might predict response to pharmacotherapy in patients with obsessive&ndash;compulsive disorder. Neuropsychiatric Disease and Treatment. Volume 13. 577–583. 8 indexed citations
7.
Yoshino, Yuta, Kentaro Kawabe, Kiyohiro Yamazaki, et al.. (2016). Elevated TREM2 mRNA expression in leukocytes in schizophrenia but not major depressive disorder. Journal of Neural Transmission. 123(6). 637–641. 12 indexed citations
8.
Iga, Jun‐ichi, Shinya Watanabe, Shusuke Numata, et al.. (2016). Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder. Human Psychopharmacology Clinical and Experimental. 31(3). 193–199. 34 indexed citations
9.
Watanabe, Shinya, Jun‐ichi Iga, Shusuke Numata, et al.. (2015). Polymorphism in the promoter of the gene for the serotonin transporter affects the age of onset of major depressive disorder in the Japanese population. Journal of Affective Disorders. 183. 156–158. 8 indexed citations
10.
Iga, Jun‐ichi, et al.. (2014). Risk of bipolar disorder and psychotic features in patients initially hospitalised with severe depression. Acta Neuropsychiatrica. 27(2). 113–118. 16 indexed citations
11.
Iga, Jun‐ichi, et al.. (2014). Psychiatric symptoms in a patient with isolated adrenocorticotropin deficiency: case report and literature review. General Hospital Psychiatry. 36(4). 449.e3–449.e5. 5 indexed citations
12.
Kinoshita, Makoto, Shusuke Numata, Atsushi Tajima, et al.. (2014). Aberrant DNA Methylation of Blood in Schizophrenia by Adjusting for Estimated Cellular Proportions. NeuroMolecular Medicine. 16(4). 697–703. 29 indexed citations
13.
Sumitani, Satsuki, et al.. (2012). Multi‐channel near‐infrared spectroscopy shows reduced activation in the prefrontal cortex during facial expression processing in pervasive developmental disorder. Psychiatry and Clinical Neurosciences. 66(1). 26–33. 16 indexed citations
14.
Nakataki, Masahito, Jun‐ichi Iga, Shusuke Numata, et al.. (2010). Gene expression and association analysis of the epithelial membrane protein 1 gene in major depressive disorder in the Japanese population. Neuroscience Letters. 489(2). 126–130. 5 indexed citations
15.
Numata, Shusuke, Jun‐ichi Iga, Masahito Nakataki, et al.. (2009). Positive association of the pericentrin (PCNT) gene with major depressive disorder in the Japanese population.. PubMed. 34(3). 195–8. 23 indexed citations
16.
Iga, Jun‐ichi, Shuichi Ueno, & Tetsuro Ohmori. (2008). Molecular assessment of depression from mRNAs in the peripheral leukocytes. Annals of Medicine. 40(5). 336–342. 32 indexed citations
17.
Numata, Shusuke, Jun‐ichi Iga, Masahito Nakataki, et al.. (2008). Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 150B(4). 527–534. 25 indexed citations
18.
Iga, Jun‐ichi, Shuichi Ueno, Ken Yamauchi, et al.. (2007). The Val66Met polymorphism of the brain‐derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 144B(8). 1003–1006. 75 indexed citations
19.
Iga, Jun‐ichi, Shuichi Ueno, Ken Yamauchi, et al.. (2006). Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(3). 658–663. 87 indexed citations
20.
Numata, Shusuke, Shuichi Ueno, Jun‐ichi Iga, et al.. (2006). Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia. Journal of Neural Transmission. 114(2). 255–259. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026